Finnish Startup Chip-Man Raises 1.4M Euro to Build Out Cell-Based Assay Platform | GenomeWeb

Earlier this month, Chip-Man Technologies, a Finnish startup company, launched Cell-IQ, its online live-cell monitoring system, at Drug Discovery Technology Europe in London.

Last week, the company took a major step in its quest to further develop the product for the drug-discovery market, securing €1.4 million ($1.8 million) in financing from Aura Capital and Finnish Industry Investment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.